The CD44 gene encodes several protein isoforms due to alternative splicing and post translational modifications. Given that CD44 variant isoform 9 (CD44v9) is expressed within Spasmolytic Polypeptide/TFF2-Expressing Metaplasia (SPEM) glands during repair, CD44v9 may be play a funcitonal role during the process of regeneration of the gastric epithelium. Here we hypothesize that CD44v9 marks a regenerative cell lineage responsive to infiltrating macrophages during regeneration of the gastric epithelium. Ulcers were induced in CD44-deficient (CD44KO) and C57BL/6 (BL6) mice by a localized application of acetic acid to the serosal surface of the stomach. Gastric organoids expressing CD44v9 were derived from mouse stomachs and transplanted at the ulcer site of CD44KO mice. Ulcers, CD44v9 expression, proliferation and histology were measured 1, 3, 5 and 7-days post-injury. Human-derived gastric organoids were generated from stomach tissue collected from elderly (>55 years) or young (14-20 years) patients. Organoids were transplanted into the stomachs of NOD scid gamma (NSG) mice at the site of injury. Gastric injury was induced in NRG-SGM3 (NRGS) mice harboring human-derived immune cells (hnNRGS) and the immune profile anlayzed by CyTOF. CD44v9 expression emerged within regenerating glands the ulcer margin in response to injury. While ulcers in BL6 mice healed within 7-days post-injury, CD44KO mice exhibited loss of repair and epithelial regeneration. Ulcer healing was promoted in CD44KO mice by transplanted CD55v9-expressing gastric organoids. NSG mice exhibited loss of CD44v9 expression and gastric repair. Transplantation of human-derived gastric organoids from young, but not aged stomachs promoted repair in NSG mouse stomachs in response to injury. Finally, compared to NRGS mice, huNRGS animals exhibited reduced ulcer sizes, an infiltration of human CD162+ macrophages and an emergence of CD44v9 expression in SPEM. Thus, during repair of the gastic epithelium CD44v9 emerges within a regenerative cell lineage that coincides with macrophage inflitration within the injured mucosa.
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site, contributing to regeneration of the epithelium [1] . To maintain a barrier to protect the granulation tissue from further injury or bacterial infection, migration of epithelial cells from the ulcer margins restores epithelial continuity via a process known as re-epithelialization [1, 2] . Re-epithelialization requires epithelial cell migration and proliferation [1, 2] . Data from our laboratory demonstrate the emergence of spasmolytic polypeptide/TFF2-expressing metaplasia (SPEM) glands localized to the base of the ulcer margin in stomach mucosa, in a position similar to where the UACL is initiated during repair in the intestine [1] . Our data suggest that SPEM represents the major reparative lineage responsible for wound healing after severe gastric injury.
SPEM is associated with increased expression of cell surface protein CD44, in particular variant isoform 9 (CD44v9) [3, 4] . Emergence of SPEM accompanied with CD44v9 expression is significant because CD44v9 is known to contribute to defence against reactive oxygen species (ROS) [3, 5, 6] . Within cancer cells, CD44v9 interacts with the glutamate-cystine transporter xCT; stabilizes the protein; and thereby potentiates defence against ROS, thus promoting tumour growth [6] . During mucosal injury and hypoxic-ischaemic conditions, ROS are continuously produced. The resulting oxidative stress is crucial for the development of epithelial apoptosis and necrosis leading to mucosal injury and erosions [7] . We may hypothesize that the emergence of CD44v9 during gastric ulcer repair potentiates defence against ROS by stabilizing xCT and thus promoting effective regeneration in response to injury. The current study is the first to investigate the role of CD44v9 in the context of gastric epithelial regeneration in response to injury.
The immune system is also a crucial player for tissue repair, including the kidney [8, 9] , and skin [10] . In particular, macrophages are key immune cells that secrete cytokines, chemokines, and pro-angiogenic factors that are necessary for repair [11] . Typically, inflammatory cues within the regional microenvironment can prime macrophages into a reparative phenotype. Inflammatory monocytes are recruited in response to cytokine cues and undergo differentiation into two distinct subsets of macrophages that are typically categorized as either classically activated (M1) or alternatively activated (M2) [9] . M2 macrophages represent various phenotypes that can be further subdivided into M2a, M2b, and M2c [12] . M2 macrophages may secrete trophic factors that suppress the pro-inflammatory response and promote wound healing [9] . For example, during skeletal muscle regeneration, macrophages are first recruited as phagocytic cells with elevated release of pro-inflammatory cytokines such as interleukin-1β (IL-1β) and tumour necrosis factor (TNF-α) and then rapidly convert into an anti-inflammatory phenotype to promote myogenesis [13] . During regeneration in the injured kidney, macrophages produce Wnt7b to stimulate tissue repair [8] . Importantly, in the stomach, studies of mouse models and human metaplastic tissues indicate that M2 macrophages promote the advancement of SPEM in the presence of inflammation and parietal cell atrophy [14] . Given that CD44v9 marks SPEM glands, here we also address the question of whether macrophages are associated with the emergence of CD44v9 during gastric repair in response to injury.
Using a gastric organoid orthotopic transplantation model, the current study demonstrates that CD44v9 emerges at the ulcer margin in response to injury and contributes to the regeneration of the gastric epithelium. Moreover, in a mouse model expressing human-derived immune cells, macrophages infiltrate the injured gastric mucosa where these immune cells may induce the emergence of CD44v9 during regeneration of the epithelium.
Materials and methods

Mouse-derived gastric organoid cultures
Organoids were derived from C57/BL6 (The Jackson Laboratory, Bar Harbor, ME, USA; stock number: 000664) or B6.129(Cg)-Cd44tm1Hbg/J (CD44-deficient) mice (The Jackson Laboratory, stock number: 005085) as previously described [15] . Briefly, mouse stomachs were dissected along the greater curvature and washed in Ca 2+ /Mg 2+ -free Dulbecco's phosphate buffered saline (DPBS). The muscle layer was removed from the mucosa and tissue was dissected into fragments and incubated at 4 ∘ C for 2 h in DPBS with 5 mM EDTA with gentle rocking. Glands were harvested by shaking in a D-sorbitol/sucrose solution for 2 min and centrifuged at 65 × g for 5 min. Glands were resuspended in Matrigel and supplemented with gastric organoid growth medium [Advanced DMEM/F12 medium (Thermo Fisher Scientific, Waltham, MA, USA), 50% Wnt conditioned medium, 10% R-spondin conditioned medium, 1× penicillin/streptomycin, 1× B27, 1× N2, 1 mM N-acetylcysteine, supplemented with gastric growth factors including bone morphogenetic protein inhibitor (Noggin; PeproTech, Rocky Hill, NJ, USA), gastrin I (Tocris, Bristol, UK), epidermal growth factor (EGF; PeproTech), Y-27632 (Sigma, St Louis, MO, USA), and fibroblast growth factor 10 (FGF-10; PeproTech)] as previously described [15] and allowed to grow for 7 days prior to transplantation into CD44-deficient mice.
Human-derived gastric organoid cultures
Human organoids were derived from young (15-21 years old) and aged (>55 years old) patient stomach tissue collected from sleeve gastrectomies (IRB Protocol number 2015-4869) as previously described [16] . Briefly, stomachs were washed with DPBS, and mucosa was collected and cut into small fragments. Tissue fragments were incubated at 37 ∘ C supplemented withCD44v9 and gastric ulcer repair 465 every 4 days [Advanced DMEM/F12 medium (Thermo Fisher), 50% Wnt conditioned medium, 20% R-spondin conditioned medium, 1× penicillin/streptomycin, 1× amphotericin/gentamicin, 1× kanamycin, 1× B27, 1× N2, 1 mM N-acetylcysteine, 10 mM nicotinamide, supplemented with growth factors including bone morphogenetic protein inhibitor (Noggin; PeproTech), gastrin I (Tocris), epidermal growth factor (EGF; PeproTech), Y-27632 (Sigma), and fibroblast growth factor 10 (FGF-10; PeproTech)] [16] . Human organoids were cultured at 37 ∘ C for 7 days prior to transplantation into NOD scid gamma (NSG) mice.
Cytometry by time-of-flight (CyTOF)
Mouse stomachs were collected from uninjured or injured areas of NRGS and huNRGS animals. Tissue was cut into fragments (approximately 2-5 mm) and transferred to pre-warmed EDTA stripping buffer [5 mM EDTA, 25 mM HEPES, 10% fetal calf serum in Hank's balanced salt solution (HBSS) (Corning, Cambridge, MA, USA; 12021CV)] for 10 min in a 37 ∘ C shaking incubator. Fragments were suspended in fresh EDTA stripping buffer for an additional 5 min in a 37 ∘ C shaking incubator. Tissue was washed with 1× HBSS and then resuspended in collagenase digestion buffer [1.5 mg/ml collagenase from Clostridium histolyticum (Sigma; C989), 20 μg/ml hyaluronidase from bovine testes (Sigma; H3884), 1× penicillin/streptomycin in RPMI (Corning; 10041CV)] for approximately 30 min in a 37 ∘ C shaking incubator or until tissue was digested. The digest was diluted in ice-cold DPBS and filtered through a 40 μm filter. Cells were centrifuged at 1200 rpm for 5 min and resuspended in 1 ml of PBS for viability staining. For 1 ml of PBS for approximately 1 × 10 7 cells, 1 μl (5 μM) of Cell-ID TM Cisplatin was added for 5 min at room temperature, according to the manufacturer's instructions (DVS Sciences, Markham, Canada; 201064). For CyTOF analysis, the MaxPar ® Cell Surface Staining Protocol was followed according to the manufacturer's instructions (Fluidigm, South San Francisco, CA, USA; PRD012). Briefly, the cisplatin reaction was quenched with 5× volume of MaxPar ® Cell Staining Buffer, and cells were centrifuged at 400 × g for 5 min. The antibody cocktail was prepared with 1 μl of each antibody for three million cells in a 100 μl staining volume of MaxPar ® Cell Staining Buffer, and cells were stained for 30 min at room temperature. Cells were washed twice in 1 ml of MaxPar ® Cell Staining Buffer and centrifuged at 400 × g for 5 min. Cells were resuspended in 1 ml of cell intercalation solution (125 nM Cell-ID Intercalator-Ir in Maxpar Fix and Perm Buffer) for shipment overnight on ice to the University of Rochester Medical Center, New York, where final washes with Maxpar water were performed according to the manufacturer's instructions, and the samples were run on a CyTOF machine. Data were analysed using Premium CytoBank Software.
Details for immunofluorescence and immunohistochemistry, whole-mount staining of gastric organoids, FACS, and statistical analyses may be found in the supplementary material, Supplementary materials and methods.
Results
CD44v9 expression emerges during gastric regeneration in response to injury
Previously, we identified CD44v9 as a marker of SPEM that emerges within the regenerating gastric epithelium during repair [4] . As such, we first investigated the pattern of CD44v9 emergence during repair in response to injury. CD44v9 expression was observed at the ulcer margin within 3 days post-injury ( Figure 1B ) and was most prominent 5 days post-injury ( Figure 1C ). As the gastric epithelium healed, CD44v9 expression was rarely expressed ( Figure 1D , E). The emergence of CD44v9 correlated with the infiltration of macrophages ( Figure 1F -I) that peaked 5 days post-injury ( Figure 1H ). These data show that the expression of CD44v9 is transient during repair of the gastric epithelium and correlates with the infiltration of macrophages.
Loss of epithelial repair in CD44KO mice is restored by gastric organoid transplantation
To study the functional role of CD44 in ulcer repair, CD44v9-expressing gastric cells were introduced into the gastric epithelium of CD44-deficient mice. This was achieved by transplantation of organoids derived from BL6 mice using the injury/orthotopic gastric organoid transplantation model (supplementary material, Figure S1A , B). Four experimental groups were studied: (1) CD44-deficient (CD44KO) mice with induced ulcers; (2) BL6 mice with induced ulcers; (3) CD44KO mice with induced ulcers and transplanted with organoids derived from BL6 mice (CD44KO BL6 ); and (4) CD44KO mice with induced ulcers transplanted with organoids derived from CD44KO mice (CD44KO 44KO ) (supplementary material, Figure S1C ). Compared with BL6 mice, which exhibited re-epithelialization by 7 days post-injury ( Figure 2E Figure 2I-M) . Importantly, compared with CD44KO BL6 mice, the CD44KO 44KO groups exhibited loss of normal repair ( Figure 2M ). Figure 2N shows representative gross morphology of the ulcer size 3 days post-injury and the sectioning position and direction of tissues. High-power magnifications of the ulcerated regions from all experimental mouse groups in Figure 2 are shown in the supplementary material, Figure S2 . These data suggest that CD44 contributes to gastric ulcer repair. CD44v9 expression correlates with increased epithelial cell proliferation CD44 is known to coordinate the proliferation of progenitor cells within the normal and metaplastic gastric epithelium [17] . This is of significance because epithelial proliferation plays a fundamental role in the regeneration of gastric tissue after injury [2] . Co-immunofluorescence staining for CD44v9 and BrdU incorporation were used to quantify the number of CD44v9/BrdU-positive proliferating cells at the ulcer margin of BL6, CD44KO, and CD44KO BL6 mice at 1, 3, 5, and 7 days post-injury ( Figure 3 ). As expected, there was no expression of CD44v9 in CD44KO mice ( Figure 3A-D) . However, there was a robust emergence of CD44v9 expression at 1, 3, 5, and 7 days post-ulcer injury in BL6 mice ( Figure 3E-H) . Importantly, there was engraftment Figure 3M ), which was consistent with an overall increase in proliferating cells that were negative for CD44v9 ( Figure 3N ). This significant induction in cell proliferation was rescued in the CD44KO BL6 mice (Figure 3M ), suggesting that CD44v9 is expressed in proliferating cells.
To identify the regeneration and differentiation of organoid cells in vivo, immunofluorescent staining for CD44v9 organoid-derived cells, parietal cells (H + K + -ATPase), and surface mucous cells (UEAI) in CD44KO mice transplanted with BL6 organoids was performed (supplementary material, Figure S3 ). These data demonstrated that CD44v9 was not expressed in parietal cells within the regenerating epithelium. Importantly, our data show that 21 days post-injury and transplantation, CD44v9 expression is decreased and rarely detected. These data suggest that the expression of CD44v9 is transient during regeneration. young mouse stomachs return to normal gastric gland morphology (supplementary material, Figure S4A ), aged animals develop severe foveolar hyperplasia (supplementary material, Figure S4B ). Moreover, human organoids derived from young patients exhibited CD44v9 expression and significantly increased epithelial cell proliferation compared with organoids derived from aged patients (supplementary material, Figure S4C -G). Organoids prior to immunostaining are shown in the supplementary material, Figure S4H , I. To determine the regenerative capacity of young and aged human-derived gastric organoids, orthotopic transplantations were performed after ulcer induction in NSG mice. The stomachs of NSG mice without transplantation of organoids did not repair 7 days post-injury ( Figure 4A ). In contrast to non-transplanted NSG mice, those transplanted with organoids derived from young patient stomachs exhibited significantly smaller ulcer sizes ( Figure 4A ). NSG mice transplanted with organoids derived from aged patient stomachs showed significantly larger ulcers 7 days post-injury, comparable to the non-transplanted group ( Figure 4A ). H&E stains of representative sections collected from the NSG mouse experimental groups are shown in the supplementary material, Figure S5 . To address the role of CD163+/CD45+ macrophages as a regulatory cell during repair, NSG mice transplanted with Aorg were co-injected with either M1 or M2 polarized macrophages isolated from humanized NRGS mice ( Figure 4A, B) . M1 and M2 polarized macrophages were aligned to human-specific genes that clearly showed unique gene profiles between the phenotypes ( Figure 4B ). In particular, CD163 was highly expressed in M2 polarized macrophages ( Figure 4B ). While 470 N Bertaux-Skeirik et al co-injection of M1 macrophages did not drive repair in NSG + Aorg mice, M2 macrophages significantly reduced the ulcer size in these animals ( Figure 4A ).
Engraftment was documented by the expression of human-specific histone (hhistone) in mouse stomachs transplanted with either young (Figure 4C , E) or aged ( Figure 4D, F) human-derived gastric organoids. Importantly, NSG mice transplanted with young human-derived gastric organoids expressed human-specific CD44v9 at the ulcer margin 7 days post-injury ( Figure 4C, E) . However, CD44v9 expression was absent in NSG mice transplanted with aged human-derived gastric organoids ( Figure 4D, F) . A representative image of an untransplanted NSG mouse stomach is shown in the supplementary material, Figure  S5D . Collectively, these data show that human-derived gastric organoids engraft within the mouse epithelium and contribute to repair. In addition, macrophages with an M2 phenotype drive repair in the stomachs of NSG mice.
Macrophage infiltration decreases in the aged, compared with young stomachs in response to injury
Macrophages are recruited to the ulcer site and are known to secrete growth factors and cytokines necessary for wound repair [2] . This is of significance given that it has been documented that M2 macrophages promote the advancement of SPEM in the presence of inflammation [14] . Indeed, we observed an increase in the myeloid cell number at the ulcer site of young mice 3 days after ulcer induction (supplementary material, Figure  S6A ). By marked contrast to the young group, aged mice did not show recruitment of macrophages 3 days after ulcer induction (supplementary material, Figure  S6B ). Tissue was collected from the ulcerated region, and the expression of T H 2 cytokines was analysed by qRT-PCR (supplementary material, Figure S6C, D) . Compared with the aged mice, within the injured tissue collected from young mouse stomachs 3 days post-injury, there was a significant increase in IL-13, IL-4, and IL-33 (supplementary material, Figure S6C , D) that is consistent with the expression of IL-33 and IL-13 as promoters of SPEM [20] . However, within the injured tissue of stomachs collected from aged mice, these increases were not observed (supplementary material, Figure S6D ). Stomachs from both the uninjured and the injured groups of mice were collected, enzymatically dissociated, and F4/80+ macrophages were isolated by FACS (supplementary material, Figure  S6E ). Gene expression indicative of M1 and M2 phenotypes was examined from FACS-sorted macrophages (supplementary material, Figure S6F , G). We observed that while the expression of M1 markers (supplementary material, Figure S6F ) was low or undetected in macrophages isolated from injured tissue, these cells expressed significant amounts of M2 markers (supplementary material, Figure S6G ). These data demonstrate that there is a skewed cytokine microenvironment observed in the young versus aged animals, which correlates with an increase in M2 macrophage markers in the young injured tissue.
Gastric repair in a humanized immune cell mouse model correlates with an infiltration of CD163+ macrophages and CD44v9 expression
To identify the role of the immune response during repair, gastric regeneration in response to injury was studied in a mouse model expressing human immune cells [21] . NRGS mice were engrafted with human umbilical cord blood (UBC) and after 8-10 weeks, the presence of human immune cells was confirmed by flow cytometric analysis ( Figure 5A, B) . Figure 5C demonstrates the percentage of human cells in the peripheral blood of NRGS mice 8-10 weeks after engraftment and also shows the percentage of human myeloid, B, T, and natural killer (NK) cells. Ulcers were induced in humanized (huNRGS, UBC engrafted) and non-engrafted (NRGS) mice and ulcer sizes were measured at 1, 3, 5, and 7 days post-injury. Compared with NRGS mice, huNRGS animals exhibited significantly reduced ulcer sizes within 3 days post-injury ( Figure 5D ), suggesting a role for the immune response in repair.
To determine the immune phenotype following ulcer injury in huNRGS mice, mass cytometry by time-of-flight (CyTOF) analysis was performed on uninjured and injured stomachs 3 days after ulcer induction. Bivariate plots compare human-derived immune cells measured in mouse uninjured and injured stomach tissue ( Figure 6A ). Heat/intensity corresponds to cell abundance in a plot region for the population indicated above the plot ( Figure 6A ). Intact cells (31.44%, red gate) were defined using event length and an iridium-based cell marker (Ir-191 intercalator) ( Figure 6A ). Among the intact cells, human leukocytes were defined as CD45+ events ( Figure 6A ). CyTOF analysis showed that compared with the uninjured huN-RGS mouse stomachs, hCD45+ cells within the injured huNRGS mouse stomachs highly expressed CD163 ( Figure 6A ), a scavenger receptor expressed exclusively on cells of the monocyte/macrophage lineage, in particular M2 macrophages [22] . In support of this, CD163+ cells were negative for T-cell markers CD4 and CD3 (supplementary material, Figure S7A , B). We identified cell subpopulations using spanning-tree progression analysis of density-normalized events (SPADE) [23] ( Figure 6B, C) . SPADE analysis is an unsupervised hierarchical clustering technique in which the size of each node is the relative cell frequency and the colour is the median intensity of the expression of each marker ( Figure 6B, C) . Compared with the uninjured stomachs of huNRGS mice ( Figure 6B, D) , there was a significant increase in human-specific CD45+/CD163+ cells infiltrating the injured tissue ( Figure 6C, D) . Infiltration of CD163+ macrophages into the injured epithelium was confirmed by immunofluorescence ( Figure 6F, H) , which was not observed in the non-engrafted NRGS Figure 6E, H) . Importantly, macrophage infiltration correlated with elevated CD44v9 expression ( Figure 6F, G) . These data demonstrate a central role for the human immune response in ulcer repair and identified the infiltration of CD163+ macrophages into the ulcer site. Moreover, macrophage infiltration correlated with increased expression of CD44v9 within the regenerating gastric epithelium.
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Discussion
In the current study, we show that CD44v9 emerges within the gastric epithelium in response to injury and may contribute to tissue regeneration. In mice lacking CD44 including CD44v9 (CD44KO), ulcer repair was impaired, as indicated by the lack of re-epithelialization and epithelial gland regeneration, persistence of prominent ulcer sizes, and loss of epithelial proliferation. Using an injury/orthotopic organoid transplantation model developed by our laboratory [4] , CD44v9-expressing gastric organoids were engrafted within the epithelium of CD44KO mice, which subsequently resulted in induced epithelial cell proliferation and accelerated ulcer repair. Wound healing requires a complex process of biological and molecular events including angiogenesis, immune cell activation, tissue remodelling, and cell migration and proliferation [2, [24] [25] [26] . The emergence of CD44v9 at the ulcer margin correlated with increased epithelial cell proliferation, which is significant because CD44 is known to coordinate the proliferation of progenitor cells within the normal and metaplastic gastric epithelium [16, 17] . Importantly, CD44v9 is known to interact with xCT, a glutamate-cystine transporter, and regulates the intracellular level of reduced glutathione [6] . Human gastrointestinal cancer cells with a high level of CD44 expression showed an enhanced capacity for glutathione synthesis and defence against ROS [5, 6, 27] . Deletion of CD44 induced loss of xCT from the cell surface and suppressed gastric cancer tumour growth [6] . The role of CD44v9 in redox regulation is significant given that oxidative stress, caused in response to injury, is crucial for the development of epithelial apoptosis and necrosis leading to ulceration [7] . We may speculate that the emergence of CD44v9 during gastric ulcer repair potentiates defence against ROS by stabilizing xCT and thus promoting effective regeneration in response to injury. Collectively, our findings suggest that CD44 is required for normal repair of the gastric epithelium. In particular, the emergence of CD44v9 may have implications in protecting the regenerating epithelium against oxidative stress during repair. However, the precise role of CD44v9 during gastric regeneration requires further investigation.
Despite evidence showing that gastric ulcers and subCD44v9 and gastric ulcer repair 473 [28, 29] . While it is established that the incidence of gastric ulcers in the elderly is primarily due to increased use of medications, including NSAIDs, and increased H. pylori infection, repair from gastric injuries is also impaired [28, 29] . Evidence suggests that ulcers do not heal normally in the aged stomach. We demonstrate here that repair within the aged stomach is compromised whereby the gastric epithelium does not heal normally.
In addition, we have reported that the aged epithelium exhibits an abnormal cell composition and decreased CD44v9 expression post-repair [4] . There are a number of mechanisms of action that prevent the gastric mucosa in the elderly from healing normally after being subjected to injury. For example, ageing is associated with impaired gastric angiogenesis [30] [31] [32] and decreased regenerative capacity, suggesting changes in epithelial stem cells [18, 19] . The capacity of organoids derived from aged human stomachs to facilitate repair in NSG mice was lost, compared with organoids derived from young patients. This correlated with not only a loss of epithelial proliferation but also a lack of CD44v9 expression within the organoid cultures. These data emphasize a critical role for the emergence of CD44v in normal ulcer repair in the human stomach. Here, we show that engraftment of cells through the transplantation of gastric organoids contributes to ulcer repair and suggests a plausible role for CD44v9 during regeneration of the gastric epithelium that is compromised with ageing. Our data showing that aged mice lack an infiltration of macrophages to the ulcer injury site are consistent with studies describing impairment of the immune response as a result of ageing [33] . CD163+/CD45+ macrophages are recruited to the gastric epithelium of young mice. Moreover, transplantation of CD163+ macrophages in NSG + Aorg mice facilitates rapid ulcer repair. Our group has published studies demonstrating, using parabiosis experiments, that the Hedgehog ligand, Sonic Hedgehog (Shh), is secreted from the gastric parietal cell in response to injury and subsequently contributes to epithelial repair [34, 35] . Importantly, we have demonstrated, using bone marrow chimera experiments, that Shh acts as a macrophage chemoattractant during the initiation of H. pylori-induced gastritis [36] . Based on these studies, we may hypothesize that Hedgehog acts as a chemoattractant for macrophages to the injured gastric epithelium.
We, and others, have previously shown that CD44v9 is a marker of SPEM [3, 4] and is lost in the human aged stomach after ulcer injury [4] . To identify a potential mechanism that results in the induction of SPEM, we turned our attention to alternatively activated, or M2, macrophages. It was recently reported that M2 macrophages promote expansion and intestinalization of SPEM in the setting of parietal cell loss and inflammation [14] . Using a novel 'humanized' mouse model, we demonstrated that engraftment of human immune cells was required for ulcer healing. Furthermore, CyTOF analysis of injured humanized mice revealed the specific up-regulation of CD163, a scavenger receptor selectively expressed on M2 macrophages. Previous studies implicate CD163 in the clearance of dead cells following tissue injury [22, 37, 38] . Using these innovative approaches, we have shown that the immune response contributes to gastric ulcer repair. Our future goals are to identify the potential mechanism by which CD163+ macrophages induce the expression of CD44v9 during ulcer repair. 
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